Ecor1 Capital, LLC

EcoR1 Capital, LLC is a registered investment adviser established in 2012, specializing in managing assets on a discretionary basis. The firm primarily invests in equity and equity-related securities issued by biotechnology companies globally, including illiquid securities. EcoR1 serves as the general partner and investment adviser to the EcoR1 Capital Funds and the EcoR1 Venture Opportunity Funds. The Capital Funds charge a 2.0% annual management fee and a performance-based allocation of 20% of net profits. Investors in the Venture Funds and SPVs are qualified purchasers. EcoR1 may waive or reduce management and performance-based fees and participates in soft dollar arrangements. Clients must invest a minimum of $25 million in the funds, with a minimum of $500 million for individually managed accounts. The firm has investment discretion but considers clients' objectives and restrictions. EcoR1 votes proxies based on clients' best interests and maintains physical custody of assets with qualified custodians. The firm reviews accounts weekly and provides regular performance reports to investors. EcoR1 may engage solicitors for client referrals and complies with a Code of Ethics. The Privacy Notice outlines the collection, use, and disclosure of personal information for limited business purposes.